Skip to content

Long term follow-up of central serous retinopathy. An observational case series.

Long term follow-up of central serous retinopathy. An observational case series. - Long term follow-up of CSR.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31151
Enrollment
100
Registered
2007-05-09
Start date
2007-05-21
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

central serous retinopathy

Interventions

None listed

Sponsors

Oogziekenhuis Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age >=18 years. - Informed consent. - FAG available from 1995 or 1996. - Diagnosis CSR in 1995 or 1996.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
At presentation: - Proportion of CSR patients with signs of DRPE - Proportion of CSR patients with bilateral involvement Long-term (10 year) follow-up: - Visual acuity of CSR and fellow eye (ETDRS chart) - Contrast sensitivity of CSR and fellow eye (Pelli Robson chart) - Color vision of CSR and fellow eye (HRR) - Standardised OCT, fundus, red free and autofluorescent photograph analysis of both eyes - Proportion of pure CSR patients that have evolved to DRPE - Proportion of patients with initial signs of DRPE that has evolved to more severe DRPE Prognostic factors: - Gender - Age onset - Use steroids - Use anxiolytics - Bilateral involvement at onset - Number of clinically documented episodes - Use laser Concomitant diseases: - Helicobacter pylori positive - Adrenal steroids values (elevated / normal / decreased) - Are there endocrinologic or cardiovascular disorders associated with earlier CSR - Stress questionnaire Effect of laser treatment: - Association of laser and longterm VA - Localisation of laser burns - Association of laser and evolution into DRPE

Secondary

MeasureTime frame
See primary parameters.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)